Immunovant IMVT
NASDAQ IMVT
$35.58 -1.47 (-3.96%)
As of: Nov 12, 2026 · 12:09 PM EST

Immunovant (IMVT) Interest & Investment Income (2019 - 2025)

Updated

Immunovant (IMVT) recorded Interest & Investment Income of $683,140 in fiscal Q2 2020 (quarter ended Sep 30, 2019), up 100.0% from the prior quarter.

Analysis

Immunovant (IMVT) Interest & Investment Income (2019 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 186.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 67.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Immunovant 7.38 Bn 3.97 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -6.89 Mn
Dec 31, 2024 -4.59 Mn
Sep 30, 2024 -6.07 Mn
Jun 30, 2024 -7.18 Mn
Mar 31, 2024 -8.38 Mn
Dec 31, 2023 -8.93 Mn
Sep 30, 2023 -3.57 Mn
Jun 30, 2023 -4.07 Mn
Mar 31, 2023 -3.48 Mn
Dec 31, 2022 -2.94 Mn
Sep 30, 2022 -1.15 Mn
Sep 30, 2019 683,140.00
Jun 30, 2019 341,558.00
API Access

Immunovant Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=IMVT&period=max&api_key=YOUR_API_KEY